RBQM ICH Whitepaper

Landing in the EU – The importance of choosing the right experts for EU/EEA QPPV

Embarking on the Next Era of Precision Medicine

In this article Angela Qu, M.D., Ph.D., Vice President, Biomarkers and Genomic Medicine, discusses the pan-cancer drug development approach guided by biomarkers.

Putting AI to Work in Your Safety Program

This article discusses the increasing use of AI in pharmacovigilance activities to increase efficiency and outcomes as data volume continues to increase.

How to Accelerate Oncology Clinical Trials through Site Relationships and Patient Insights

Learn how all stakeholders benefit when patients and their insights are at the heart of every aspect of clinical development.

Decentralized clinical trials - A more patient-centric approach

Decentralized clinical trials, where portions of a study are conducted outside a traditional trial site, offer new opportunities — and new hope — for patients struggling with inflammatory conditions.

Entering a new age of evidence generation: synthetic control models

Expert perspectives from Parexel's Leanne Larson, Senior Vice President and WW Head of Real-World Evidence

Regulatory, clinical and logistics challenges of ATMPs in clinical research

This article explores the nature and manufacturing process of ATMP and how clinical professionals can execute the development and marketing of these therapies.

Real-world evidence for more efficient, patient-focused trials

Top Ten Rules for Success in DCTs

In this article, we summarize what we’ve learned and outline the top 10 rules for a successful DCT.

Operationalizing Cell and Gene Therapy Trials

The science of ethnobridging

FSP future view: the functional service provider model in 2025

This article shares Parexel’s view of change drivers, essential infrastructure components, and advancing FSP capabilities over the next five years.

Is your FSP vision 2020?

This article discusses the current FSP models and provides expert tips for choosing the right one.

The Rise of FSP Outsourcing

In this article published in Applied Clinical Trials, industry experts share their thoughts on the evolution of the functional service provider model, as demand for flexible resourcing grows.

The Evolution of FSP Article

This article discusses the evolution of FSP models from staff augmentation for discrete functions to more flexible, customized models to fit a sponsors’ needs, flexing with fluctuating outsourcing.

Parexel FSP Culture Map

Learn how we leverage our Parexel FSP Culture Map™ process to align skills and personal qualities with your organization to drive project success.

Real-world evidence in APAC

How China and Japan are approaching early challenges in using real-world evidence.

EMWA Regulatory Matters Vol 29 Issue 1 March 2020 - J Wolfe and S Takidar